DOT Regulations

This week, the National Drug Control Policy Director Gil Kerlikowske released the 2011

Independent of the FMCSA and Executive activities, a bill was introduced in the U.S. Senate on April 7, 2011 that authorizes funds and directs DOT to develop the database and gives the database the catchy name of National Clearinghouse for Alcohol and Controlled Substance Test Results of Commercial Motor Vehicle Operators. The basic highlights of the bill are:

The creation of a national database for tracking drug and alcohol violations of commercial motor vehicles is an ambitious project that has been in the works at DOT and the Federal Motor Carrier Safety Administration (FMCSA) for several years. There is also apparent cooperation between DOT and HHS on the database  as evidenced in HHS laying the foundation for data capture in the form of the new Custody and Control Form that requires collectors to note for what DOT modality the drug test is being performed.

Information on these issues were discussed in sessions at the recent FTA Drug and Alcohol Conference by Jerry Powers, FTA, Drug and Alcohol Program Manager; Mark Snider, ODAPC; and Jim Keenan, FMCSA Drug and Alcohol Program Manager.

FMCSA proposes to amend the Federal Motor Carrier Safety Regulations (FMCSRs) to incorporate by reference the most recent version of the American Association of Motor Vehicle Administrators, Inc.’s (AAMVA) Commercial Driver’s License Information System (CDLIS) State Procedures Manual (the Manual).

School Transportation Vehicles: Testing Requirement

34520.3

.  

The US States Drug Enforcement Administration (DEA) used its emergency scheduling authority to control five chemicals used to make, "so-called fake pot products. Except as authorized by law, this action makes possessing and selling these chemicals or the products that contain them illegal in the US."

BELOW IS THE COMPLETE GUIDANCE ON DOT AND MEDICAL MARIJUANA

DOT OFFICE OF DRUG AND ALCOHOL POLICY AND COMPLIANCE NOTICE
Recently, the Department of Justice (DOJ) issued guidelines for Federal prosecutors in states that have enacted laws authorizing the use of “medical marijuana.”